[1]
DeVita VT Jr, The evolution of therapeutic research in cancer. The New England journal of medicine. 1978 Apr 20; [PubMed PMID: 634335]
[4]
FARBER S,DIAMOND LK, Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. The New England journal of medicine. 1948 Jun 3; [PubMed PMID: 18860765]
[5]
ELION GB,SINGER S,HITCHINGS GH, Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. The Journal of biological chemistry. 1954 Jun; [PubMed PMID: 13174557]
[6]
NOWELL PC,HUNGERFORD DA, Chromosome studies on normal and leukemic human leukocytes. Journal of the National Cancer Institute. 1960 Jul; [PubMed PMID: 14427847]
[7]
Huggins C,Hodges CV, Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA: a cancer journal for clinicians. 1972 Jul-Aug; [PubMed PMID: 4625049]
[8]
Fisher B,Costantino JP,Wickerham DL,Redmond CK,Kavanah M,Cronin WM,Vogel V,Robidoux A,Dimitrov N,Atkins J,Daly M,Wieand S,Tan-Chiu E,Ford L,Wolmark N, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute. 1998 Sep 16; [PubMed PMID: 9747868]
[9]
Baum M,Brinkley DM,Dossett JA,McPherson K,Patterson JS,Rubens RD,Smiddy FG,Stoll BA,Wilson A,Lea JC,Richards D,Ellis SH, Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer. Lancet (London, England). 1983 Aug 20; [PubMed PMID: 6135926]
[10]
McLaughlin P,Grillo-López AJ,Link BK,Levy R,Czuczman MS,Williams ME,Heyman MR,Bence-Bruckler I,White CA,Cabanillas F,Jain V,Ho AD,Lister J,Wey K,Shen D,Dallaire BK, Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Aug; [PubMed PMID: 9704735]
[12]
Adjei AA,Hidalgo M, Intracellular signal transduction pathway proteins as targets for cancer therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Aug 10; [PubMed PMID: 15983388]
[13]
Tan AD,Willemsma K,MacNeill A,DeVries K,Srikanthan A,McGahan C,Hamilton T,Li H,Blanke CD,Simmons CE, Tyrosine kinase inhibitors significantly improved survival outcomes in patients with metastatic gastrointestinal stromal tumour: a multi-institutional cohort study. Current oncology (Toronto, Ont.). 2020 Jun; [PubMed PMID: 32669934]
[14]
Mohyuddin GR,Aziz M,Britt A,Wade L,Sun W,Baranda J,Al-Rajabi R,Saeed A,Kasi A, Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review. BMC cancer. 2020 Jun 3 [PubMed PMID: 32493233]
[15]
Mizuta Y,Tokuda K,Guo J,Zhang S,Narahara S,Kawano T,Murata M,Yamaura K,Hoka S,Hashizume M,Akahoshi T, Sodium thiosulfate prevents doxorubicin-induced DNA damage and apoptosis in cardiomyocytes in mice. Life sciences. 2020 Jul 13; [PubMed PMID: 32673667]
[16]
Al-Khatib T,Cohen N,Carret AS,Daniel S, Cisplatinum ototoxicity in children, long-term follow up. International journal of pediatric otorhinolaryngology. 2010 Aug; [PubMed PMID: 20846503]
[17]
Arango M,Cardona D, Hemorrhagic Cystitis after Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: Protective Effect of MESNA Continuous Infusion. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020 May 15; [PubMed PMID: 32417488]
[18]
Gamble M,Carroll E,Wright GC,Glode AE, Comparison of two different intravenous serotonin antagonists used for chemotherapy-induced nausea and vomiting prophylaxis in patients treated with moderately emetogenic risk regimens: A retrospective analysis from a large academic medical center. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2020 Jul 6; [PubMed PMID: 32633661]
[19]
Peng C,Li X,Huang H,Liu T,Wang Z,Fang X,Hong H,Li F,Ren Q,Liu S,Tian Y,Lin T, A prospective, crossover randomized trial of the optimal timing for leucovorin rescue after high-dose methotrexate management in adult non-Hodgkin's lymphoma patients. Leukemia [PubMed PMID: 32316801]
[20]
Wilairat P,Kengkla K,Kaewpanan T,Kaewthong J,Ruankon S,Subthaweesin C,Stenehjem DD,Saokaew S, Comparative efficacy and safety of interventions for preventing chemotherapy-induced oral mucositis in adult cancer patients: a systematic review and network meta-analysis. European journal of hospital pharmacy : science and practice. 2020 Mar; [PubMed PMID: 32133137]